Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04537650 · ClinicalTrials.gov registry record
Swallowing Impairment After COVID-19 Infection
A clinical trial, sponsored by University Health Network, Toronto.
- Completed
- Registry status
- 44
- Enrollment target
NCT04537650: Completed study, sponsored by University Health Network, Toronto.
NCT04537650 is a clinical trial that has completed, run by University Health Network, Toronto. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04537650 has completed, sponsored by University Health Network, Toronto.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
This is an observational study, in which people recovering from COVID-19 infection will attend an outpatient clinic for a comprehensive swallowing assessment. The assessment will include a videofluoroscopy, measurement of respiratory-swallow coordination using a digital stethoscope, measures of tongue and cough strength and patient reported measures that will help us to understand the presence and impact of swallowing impairment (dysphagia) in this population.
Primary Outcome
Frequency of participants demonstrating airway invasion on thin liquids, defined as Penetration-Aspiration Scale score of 3 and higher (Rosenbek et al., 1996). Higher scores indicate worse function.
Interventions
- DIAGNOSTIC_TEST Videofluoroscopic Swallowing Study (VFSS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2022-03-31 |
What the finished NCT04537650 record still lists
NCT04537650 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Videofluoroscopic Swallowing Study (VFSS) is the first listed.
NCT04537650 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04537650 about?
NCT04537650 is a clinical study titled "Swallowing Impairment After COVID-19 Infection". This is an observational study, in which people recovering from COVID-19 infection will attend an outpatient clinic for a comprehensive swallowing assessment. The assessment will include a videofluoroscopy, measurement of respiratory-swallow coordination using a digital stethoscope, measures of tong...
What is the current status of trial NCT04537650?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2021-01-01. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT04537650?
The interventions under investigation include: Videofluoroscopic Swallowing Study (VFSS) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04537650?
This trial is sponsored by University Health Network, Toronto, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI